ICRA has revised its outlook on the domestic pharmaceutical industry from stable to negative in view of the lockouts in parts of China, amid the coronavirus outbreak. Of the total imports of active pharmaceutical ingredients (APIs) and intermediates into India, China accounts for 65-70%, while in specific APIs like cephalosporins, azithromycin and penicillin, the dependence is as high as 80-90%.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/37KgqDx
